Y. Van Lecrubier
#136,237
Most Influential Person Now
Y. Van Lecrubier's AcademicInfluence.com Rankings
Download Badge
Biology
Y. Van Lecrubier's Degrees
- PhD Psychiatry Université Paris Cité
Why Is Y. Van Lecrubier Influential?
(Suggest an Edit or Addition)Y. Van Lecrubier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. (1998) (19814)
- The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI (1997) (3137)
- The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability (1997) (1933)
- Mini International Neuropsychiatric Interview (2013) (820)
- Depression Comorbid with Anxiety: Results from the WHO Study on Psychological Disorders in Primary Health Care (1996) (540)
- Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. (2001) (474)
- Treatment resistant depression: methodological overview and operational criteria (1999) (395)
- Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance (2000) (373)
- Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. (2007) (373)
- An international study of psychological problems in primary care. Preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care'. (1993) (351)
- Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. (2000) (320)
- DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI (1998) (287)
- Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder (1996) (216)
- The burden of depression and anxiety in general medicine. (2001) (212)
- Treatment of Negative Symptoms in Schizophrenia with Amisulpride (1995) (206)
- Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. (2007) (196)
- Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects (1998) (167)
- A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers (1995) (155)
- Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. (2004) (155)
- Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. (2000) (153)
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. (2002) (152)
- Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. (1995) (149)
- Prevalence and recognition of anxiety syndromes in five European primary care settings (1998) (147)
- Quality of life in patients with bipolar I depression: data from 920 patients. (2004) (145)
- A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder (1997) (143)
- The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. (1999) (141)
- Generalized anxiety disorder (ICD‐10) in primary care from a cross‐cultural perspective: a valid diagnostic entity? (2000) (140)
- Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. (1998) (131)
- Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder (1997) (131)
- A Beta Adrenergic Stimulant (Salbutamol) versus Clomipramine in Depression: A Controlled Study (1980) (130)
- Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. (1997) (115)
- A European perspective on social anxiety disorder (2000) (115)
- Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. (1999) (110)
- Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. (2001) (110)
- Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia (1999) (103)
- Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study (2002) (101)
- The impulsivity rating scale (IRS): preliminary results (1995) (97)
- Form, frequency and burden of sleep problems in general health care: a report from the WHO Collaborative Study on Psychological Problems in General Health Care (1996) (94)
- Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression (2011) (94)
- Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. (1998) (91)
- CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects (1999) (82)
- Efficacy of venlafaxine in depressive illness in general practice (1997) (81)
- The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6‐month double‐blind controlled clinical trial (2006) (81)
- Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients (2009) (80)
- Consensus statement on depression, anxiety, and oncology. (2001) (80)
- Comorbidities in social phobia (1997) (79)
- Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder (2011) (71)
- Depressed Subjects Unwittingly Overreport Poor Social Adjustment Which They Reappraise When Recovered (1991) (70)
- Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. (2003) (70)
- Central D2 Receptors and Negative Symptoms of Schizophrenia (1994) (69)
- Prescribing patterns for depression and anxiety worldwide. (2001) (68)
- Is depression under‐recognised and undertreated? (1998) (66)
- Anxiety and impulsivity levels identify relevant subtypes in adolescents with at-risk behavior. (2003) (65)
- Current issues in bipolar disorder: A critical review (2007) (63)
- Panic and depression: a worldwide primary care perspecctive (1998) (63)
- ANTIDEPRESSANT EFFECT OF SALBUTAMOL (1977) (62)
- Comorbidity in social anxiety disorder: impact on disease burden and management. (1998) (61)
- Posttraumatic stress disorder in primary care: a hidden diagnosis. (2004) (60)
- The impact of comorbidity on the treatment of panic disorder. (1998) (59)
- Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD) (2010) (58)
- How do you define remission? (2002) (57)
- Clinical efficacy of milnacipran: placebo‐controlled trials (1996) (56)
- Antimanic effect of clonidine. (1980) (53)
- Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine (1989) (53)
- Relationship between impulsivity and platelet serotonin content in adolescents (2000) (52)
- Efficacy of clonidine in 24 patients with acute mania. (1986) (51)
- Efficacy of reversible inhibitors of monoamine oxidase‐A in various forms of depression (1990) (50)
- Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant (1978) (49)
- The influence of comorbidity on the prevalence of suicidal behaviour (2000) (48)
- Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. (2006) (47)
- Refinement of diagnosis and disease classification in psychiatry (2008) (47)
- A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. (2011) (46)
- Critical issues in the treatment of affective disorders (1995) (43)
- Is severe depression a separate indication? (1999) (41)
- 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder (2010) (41)
- Maintenance therapies for classic and other forms of bipolar disorder. (2000) (40)
- Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. (1997) (40)
- Consensus statement on depression, anxiety, and cardiovascular disease. (2001) (40)
- Social phobia in general health care (1994) (39)
- Physical components of depression and psychomotor retardation. (2006) (39)
- ECNP consensus meeting March 2000: Nice guidelines for investigating efficacy in bipolar disorder (2001) (39)
- The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted in 14 countries. (1994) (38)
- Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia (2001) (37)
- Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxiety. (2007) (37)
- The Ham D6 is more homogenous and as sensitive as the Ham D17☆ (2007) (36)
- Antagonism by d,1-propranolol of imipramine effects in mice. (1979) (36)
- Beta-receptor stimulation in the treatment of depression. (1984) (36)
- APRAND programme: an intervention to prevent relapses of anxiety and depressive disorders: First results of a medical health promotion intervention in a population of employees (2006) (35)
- Depressive illness and disability (2000) (35)
- [Diagnostic structured interviews in child and adolescent's psychiatry]. (2004) (34)
- [Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation]. (1999) (33)
- Social phobia in primary care: level of recognition and drug use (1996) (33)
- Consensus statement on depression, anxiety, and functional gastrointestinal disorders. (2001) (32)
- Beta‐adrenergic stimulation and antidepressant activity (1981) (32)
- Awareness of Metabolic Concerns in Patients With Bipolar Disorder: A Survey of European Psychiatrists (2008) (32)
- A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder (2005) (31)
- Physician observations and perceptions of positive and negative symptoms of schizophrenia: A multinational, cross-sectional survey (2007) (29)
- Relationships Among Anxiety Disorders: Patterns and Implications (2007) (28)
- Establishing non-inferiority in treatment trials in psychiatry — guidelines from an Expert Consensus Meeting (2008) (27)
- A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. (2001) (27)
- Negative symptoms in schizophrenia: considerations for clinical trials (1994) (27)
- The Ham D(6) is more homogenous and as sensitive as the Ham D(17). (2007) (27)
- Treatment of positive and negative symptoms: pharmacologic approaches. (1990) (27)
- Prevalence of subthreshold forms of psychiatric disorders in persons making suicide attempts in Hungary (2000) (25)
- Drug treatment of panic disorder: early response to treatment as a predictor of final outcome (1990) (24)
- Auditory hallucinations in pre-pubertal children (2007) (24)
- Differences between prescription and consumption of antidepressants and anxiolvtics (1998) (24)
- Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine (1996) (23)
- Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression (2012) (22)
- Schizophreniform catatonia on 6 cases secondary to hydrocephalus with subthalamic mesencephalic tumor associated with hypodopaminergia. (1996) (20)
- Clinical utility of venlafaxine in comparison with other antidepressants (1995) (20)
- A New Treatment Algorithm for Posttraumatic Stress Disorder (2005) (19)
- Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs. (1991) (19)
- Characteristics, recognition and treatment of dysthymics in primary care (1998) (19)
- Risk-Benefit Assessment of Newer Versus Older Monoamine Oxidase (MAO) Inhibitors (1994) (18)
- S.27.02 A partial D3 receptor agonist in schizophrenia (2003) (18)
- Amisulpride vs Risperidone in Chronic Schizophrenia: Results of a 6-Month, Double-Blind Study (2003) (18)
- Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology. (1999) (17)
- Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study (2010) (17)
- [Study of a beta-adrenergic stimulant and its antidepressant activity in man]. (1977) (16)
- Over-reporting of maladjustment by depressed subjects (1991) (16)
- Auditory hallucinations in pre-pubertal children. A one-year follow-up, preliminary findings. (2007) (15)
- Amisulpride: Progress and Outcomes (2002) (15)
- Dysthymia in neurological disorders. (1996) (14)
- Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia (1999) (13)
- Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression (1995) (13)
- Favourable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study. (1981) (13)
- Isolation-induced social behavioral deficit: A proposed model of hyperreactivity with a behavioral inhibition (1989) (13)
- Prevalence of recurrent brief depression in primary care (2005) (12)
- Dopamine in the Pathophysiology and Treatment of Schizophrenia : New Findings (2003) (12)
- Is amisulpride an 'atypical' atypical antipsychotic agent? (2000) (11)
- Improvement by amisulpride of the negative syndrome in non-psychotic subjects: a preliminary study (1988) (11)
- ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder (2004) (11)
- Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) (1997) (11)
- Food and Drug Interactions with Monoamine Oxidase Inhibitors (1996) (11)
- Recurrent brief depression: clinical and epidemiological issues. (1995) (11)
- Central D2 receptor blockade and antipsychotic effects of neuroleptics. Preliminary study with positron emission tomography (1990) (11)
- Improved ability to identify symptoms of major depressive disorder (MDD) in general practice (2001) (10)
- The place of anxiety in depressive symptomatology. (1983) (10)
- No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression (2011) (10)
- [Amisulpride, neuroleptic and antinegative action]. (1990) (10)
- Isolation increases the responses to beta-adrenergic stimulation in mice. (1980) (9)
- AMISULPRIDE VERSUS IMIPRAMINE AND PLACEBO IN DYSTHYMIA (1992) (9)
- TREATMENT OF DYSTHYMIA WITH LOW‐DOSE AMISULPRIDE VERSUS AMINEPTINE (1992) (9)
- [The Psychotic Anxiety Scale (PAS). Evaluation of inter-rater reliability and correspondence factorial analysis]. (1989) (9)
- Recognizing and Effectively Treating Depression (2008) (9)
- Effect of chronic lithium treatment on isolation-induced behavioral and biochemical effects in mice. (1981) (9)
- Pharmacological interventions in dysthymia (1996) (8)
- PMC66 USE OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (M.I.N.I.) – VERSION 6 – IN AN INTERNATIONAL STUDY (2009) (8)
- Recognition and treatment of patients with sleep problems in general health care (1996) (8)
- Pharmacological Classification of Benzamides (1984) (7)
- Psychotropic Drug Prescription in Primary Care (1996) (7)
- [A new approach to the treatment of depression: salbutamol]. (1978) (7)
- Antidepressant use in general practice. (1996) (6)
- Risk factors for suicide attempts: Epidemiological evidence (1998) (6)
- Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder (2008) (6)
- Progress in Dopamine Research Schizophrenia : A Guide for Physicians (2004) (5)
- The Identification of Psychiatric Disorders in Primary Care (1996) (5)
- Guidelines for the investigation of efficacy in social anxiety disorder.ECNP Consensus Meeting (2004) (5)
- GAD: Current treatment and costs (2000) (5)
- Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes (2010) (5)
- Modulation of dopamine D2 receptors as a basis of antipsychotic effect (2003) (4)
- [Classification of neuroleptics]. (1984) (4)
- The management of depression: An international naturalistic survey (2008) (4)
- P.3.22 Predictive factors of resistance to antidepressant treatment: results from a European multicentre study (2005) (4)
- Clonidine and neuroleptic-resistant mania. (1988) (4)
- Comparative efficacy of antidepressants. Discussion (1992) (4)
- S-19-3 Dopaminergic influence on motivational processes: Improving positive and/or negative symptom (1995) (3)
- P.1.084 Quantitative video-analysis of gait in depressed inpatients (1996) (3)
- [Clonidine versus a placebo trial in manic disorder]. (1989) (3)
- Amisulpride as a model: clinical effects of a pure dopaminergic agent (2003) (3)
- S-10-4 Social phobia: Defining thresholds for treatment intervention (1996) (3)
- Functional Brain Imaging of Negative Symptoms of Schizophrenia (1996) (3)
- Afternoon increase in plasma cortisol in depressed patients receiving an antiglucocorticosteroid in the morning. (1986) (2)
- Efficacy of 5HT3 receptor antagonists (1993) (2)
- [Antidepressive effect of a beta adrenergic stimulant]. (1977) (2)
- P.1.152 Use of the mini-international neuropsychiatric interview to diagnose comorbid depression and anxiety (1997) (2)
- Noradrenergic drugs and affective disorders. (1982) (2)
- Developing cross-national CME for mental disorders in Europe* (2001) (2)
- [Double-blind controlled trial comparing alprazolam and lorazepam in ambulatory anxious patients]. (1984) (2)
- [Cortisol secretion in depressed patients. Review of the literature]. (1988) (2)
- Predictive factors of resistance to antidepressants in bipolar depression: results from a European multicentre study (2006) (2)
- [Favorable effect of yohimbine hydrochloride on orthostatic hypotension induced by clomipramine]. (1979) (2)
- Review: Adding SSRIs to antipsychotics does not improve negative symptoms in people with schizophrenia (2007) (2)
- Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs. (1993) (2)
- [Schizophrenia, from classification to dimensions: value of longitudinal studies]. (1997) (2)
- [Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine (author's transl)]. (1980) (2)
- 76-7 CSF 5-HIAA and HVA levels are lower in impulsive as compared to non impulsive suicide attempters and controls immediately after a violent suicide attempt (1997) (2)
- [Side effects and risks of benzodiazepines]. (1982) (1)
- [Central dopaminergic receptors and negative symptoms in schizophrenia]. (1992) (1)
- Consensus Statement on the Benefit to the Community of ESEMeD Survey Data on Depression and Anxiety (2007) (1)
- Should Diagnosis Drive Development of Psychotropic Drugs (2007) (1)
- Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP) (2008) (1)
- Pharmacotherapy and the role of new and classic antidepressants (1995) (1)
- Multiple pharmacological mechanisms and clinical targets for neuroleptics: should a more operational classification be considered? (1987) (1)
- Impact of depression and mania on quality of life in bipolar compared to unipolar depression and United Kingdom population norms (2002) (1)
- Focus on Depression and Anxiety Disorders in General Medicine (2001) (1)
- Efficacious and Safe Psychotropics Not Available in the United States (1996) (1)
- THE CONCEPT OF NEGATIVE SYMPTOMS (1998) (1)
- P.2.c.038 Efficacy of levomilnacipran in improving symptoms and functional impairment associated with major depressive disorder (2010) (1)
- S-9-3 SSRIs in panic disorder (1995) (1)
- The efficacy of hypericum: Does severity matter? (2001) (1)
- Qualitative changes in symptomatology before and after treatment to remission in generalised anxiety disorder and major depression (2006) (1)
- Long-term treatment of depression (1993) (1)
- Comparison of venlafaxine and imipramine in depressive illness (1998) (1)
- Promising psychopharmacologic medications not available in the USA (1995) (1)
- Demographic and clinical characteristics of bipolar I patients enrolled in two large, placebo-controlled maintenance studies (2002) (1)
- The importance of national therapeutic strategies for the treatment of sub-threshold depressive disorders (1993) (1)
- [Neurasthenia and thymasthenia]. (1994) (1)
- C.17.01 Improving the accuracy of diagnosis of depression (2008) (1)
- The Mini in Primary Care (1997) (1)
- Promising medications not available in the United States (1994) (1)
- [A qualitative study of clinical change in population of salbutamol-treated hospitalized depressives (author's transl)]. (1982) (1)
- S-47-2 Benzodiazepines use in the medically III population: Impact of psychopathology and somatic morbidity (1996) (0)
- WHO study: Somatoform disorders in general practice, an epidemiological survey (1998) (0)
- Contents of volume 250 · 2000 (2000) (0)
- [Therapeutic effect of amoxapine. A pragmatic study]. (1991) (0)
- O-26-8 Severe depression: Recognition and treatment (1996) (0)
- DEPRESSION : Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Biological and Psychosocial Correlates of Perimenopausal Depression : Implications for Treatment (2007) (0)
- Predicting long term outcome with sertraline and paroxetine in depressed patients (2001) (0)
- Introduction (2021) (0)
- P.3.a.034 Negative symptoms of schizophrenia: analysis of a multinational, cross-sectional survey of physician perceptions (2006) (0)
- S-10-5 Psychotropic drugs use in patients with anxious or depressive disorders vs subthreshold syndromes (1996) (0)
- P.2.109 Identification of determinants of treatmentresponse to amisulpride using multivariate regression analysis (2004) (0)
- [Methodological constraints in evaluating anti-deficit effects]. (1996) (0)
- C.12.01 Current controversies in depression treatment: a hot topics panel (2006) (0)
- C.18.01 The importance of recognising negative symptoms (2006) (0)
- The biological, functional and personal consequences of stress (2005) (0)
- S-38-3 Comorbidities in social phobia (1996) (0)
- [Diagnosis of side effects applied to a particular area: psychiatry]. (1981) (0)
- Mixed anxiety-depression: prevalence recognition and disability in the WHO-PPGHC study (1994) (0)
- S.17.01 Social phobia: Treatment usage in general health care (1996) (0)
- Social adjustment of patients with depression is improved with effective treatment: a venlafaxine study in general practice (2000) (0)
- P.3.02 Personality traits as predictors of treatment response in patient with affective disorder (2004) (0)
- Remission analysis of patients with panic disorder treated with paroxetine (2002) (0)
- In vivo ASSESSMENT OF DOPAMINERGIC VARIABLES IN SCHIZOPHRENIA. (1992) (0)
- PR 04 . ECNP / AEP SYMPOSIUM PR 04 . 01 Factors associated to resistant depression (2007) (0)
- [A strategy for therapy of depressive disorders and anxiety disorders by a health education intervention in medical consultations: the results of the APRAND program]. (2007) (0)
- False beliefs: The current treatment of patients with depression (2003) (0)
- Factors associated to resistant depression (2007) (0)
- PMH32 ANALYSIS OF A MULTINATIONAL, CROSS-SECTIONAL SURVEY OF PHYSICIAN DESCRIPTIONS AND PERCEPTIONS OF PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA (2006) (0)
- The role of physical symptoms in depression and in achieving remission (2006) (0)
- Antipsychotic drugs acting via unusual mechanisms: clinical and therapeutic approach (1991) (0)
- S-10-3 Efficacy of pharmacological treatment in short term anxiety (1996) (0)
- Metabolic syndrome among patients with bipolar disorder: Current perspectives of European psychiatrists (2007) (0)
- The epidemiology and differential diagnosis of negative symptoms in schizophrenia (1998) (0)
- Behavioral Pharmacology and Clinical Antidepressant Effects of β-Adrenergic Agonists (1989) (0)
- Contents, Vol. 28, Supplement 1, 1995 (1995) (0)
- Novel Antipsychotics as Antidepressants: Differential Effects on Mood Disorders in Schizophrenia (1997) (0)
- Introduction: Update on Posttraumatic Stress Disorder (2004) (0)
- Clinical and epidemiological characteristics of resistant depression (1998) (0)
- SAT02.02 Optimising long-term treatment of depression (2000) (0)
- S37.02 The influence of comorbidity on the prevalence of suicidal behaviour (2000) (0)
- Prevalence of mental disorders and their subthreshold forms in suicide attempters in Hungary (2000) (0)
- PS02.01 Social phobia (2000) (0)
- Practical aspects of the utilization of double-blind trials using adjusted doses of psychotropic drugs (1983) (0)
- [Brief recurrent depressions and their consequences. Epidemiological study]. (1994) (0)
- [Treatment of subsyndromes, or: consultation for chemotherapy of subsyndromes of depressive states]. (1994) (0)
- Clonidine and Neuroleptic-Resistant Mania (1988) (0)
- P-1-14 Prevalence of psychiatric comorbidity in patients with diabetes meltitus type I with and without poor metabolic control (1995) (0)
- depression: a controlled study. A beta adrenergic stimulant (salbutamol) versus clomipramine in (2012) (0)
- The relevance of recurrent bried depression in primary care (1994) (0)
- Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists (2008) (0)
- From serendipity to selectivity (1994) (0)
- [Letter: Value and limitation of assays of lithium in the saliva]. (1976) (0)
- Suicidal behaviour in amisulpride treated patients: A pooled review of 11 clinical studies (1999) (0)
- Who is treated, non treated and/or over treated in primary care? (1998) (0)
- S-29-1 Pharmacological treatment of OCD: Are the specific serotonin reuptake inhibitors superior to clomipramine? (1996) (0)
- SAT-3-4 Efficacy and safety of venlafaxine in major depression (1995) (0)
- Recognition and subtyping of atypical depression by French Practitioners (1993) (0)
- 39-92 Impulsivity and platelet serotonin content in adolescents (1997) (0)
- Pharmacology and neuroimaging of antidepressant action. (2012) (0)
- The Place of the SSRIs and Fluvoxamine in the Treatment of Patients with Depression (1992) (0)
- Prophylaxis of bipolar disorder (1999) (0)
- S.02.05 European research programme on treatment resistant depression (2007) (0)
- Brain Imaging of Dopaminergic Variables in Negative Schizophrenia, and during Neuroleptic Treatment (1996) (0)
- P.8.a.013 An independent clinician group of excellence to improve psychiatric clinical trials in France (2008) (0)
- 70-3 Treatment of subsyndromal depression and mixed anxiety and depressive disorder (1997) (0)
- [The role of norepinephrine in affective disorders (author's transl)]. (1979) (0)
- P.1.095 Unipolar and bipolar depression: Demographic and clinical differences. Results from a European multicenter study (2004) (0)
- Depression and smoking. Cause or consequence? (2002) (0)
- Neuroleptics and Drug-Induced Modifications of Behaviour in Animals and Men (1985) (0)
- Is poor premorbid functioning related to the deficit syndrome of schizophrenia? (2000) (0)
- Severe Depression: Recognition and Treatment (1996) (0)
- Evidence for the role of noradrenaline in some effects of quipazine (2004) (0)
- S-68-3 The clinical subliminal features of dysthymia (1996) (0)
This paper list is powered by the following services:
